DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ advanced 1.73% to $23.46 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.27% to 17,738.16 and the Dow Jones Industrial Average rising 0.70% to 41,113.97.
The stock's rise snapped a two-day losing streak.
Catalyst Pharmaceuticals Inc. closed 10.31% below its 52-week high of $26.16, which the company achieved on March 24th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 1.83% to $157.30, Pfizer Inc. $(PFE)$ fell 0.39% to $22.79, and Abbott Laboratories $(ABT)$ rose 0.67% to $133.95.
Trading volume (1.3 M) remained 4,534 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 7, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 07, 2025 17:26 ET (21:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。